tldrdailynews.com logo

Afeyan warns U.S. science backlash could slow biotech innovation

1 min read
Source: statnews.com
Afeyan warns U.S. science backlash could slow biotech innovation
Photo: statnews.com
TL;DR

Investor Noubar Afeyan warns in his annual letter that a domestic backlash against science and policy cuts could slow biomedical advances, threaten life expectancy, and widen the gap with China, a message delivered at the JPMorgan Healthcare Conference.

Topics:businessscience#biotech-policy#flagship-pioneering#jpmorgan-healthcare-conference#noubar-afeyan#science#science-backlash
Share this article
  1. Investor behind Moderna says U.S. policy is ‘taking a sledgehammer to our miracle machine’  statnews.com
  2. ‘An undoing of the scientific method’: Flagship CEO warns of government threats to US biotech industry  Fierce Biotech
  3. Moderna chair warns of ‘dystopia’ amid US science pullback  Yahoo
  4. Flagship CEO Calls Out Attacks on Science, Warns of China Dominance  BioSpace
  5. Pharmalittle: We're reading about a 'sledgehammer' to innovation, longevity medicine, and more  statnews.com

Want the full story? Read the original reporting

Read on statnews.com